| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.33B | 137.36B | 54.11B | 49.00B | 48.50B | 50.45B |
| Gross Profit | 65.64B | 62.17B | 54.11B | 49.00B | 48.50B | 50.45B |
| EBITDA | 14.73B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 22.14B | 20.36B | 16.23B | 14.61B | 15.79B | 16.04B |
Balance Sheet | ||||||
| Total Assets | 2.40T | 2.33T | 2.17T | 2.01T | 1.92T | 1.71T |
| Cash, Cash Equivalents and Short-Term Investments | 59.35B | 165.28B | 167.13B | 212.00B | 240.60B | 231.03B |
| Total Debt | 390.27B | 834.96B | 779.52B | 774.59B | 699.12B | 567.25B |
| Total Liabilities | 2.26T | 2.19T | 2.04T | 1.89T | 1.81T | 1.61T |
| Stockholders Equity | 140.72B | 139.09B | 127.09B | 117.66B | 108.06B | 98.67B |
Cash Flow | ||||||
| Free Cash Flow | 71.25B | 52.98B | 20.86B | 23.35B | 19.44B | 58.86B |
| Operating Cash Flow | 73.39B | 55.22B | 23.14B | 26.08B | 21.94B | 61.04B |
| Investing Cash Flow | -46.90B | -68.57B | -20.89B | -28.27B | -57.05B | -57.35B |
| Financing Cash Flow | -13.77B | -6.71B | -8.15B | -9.83B | -2.19B | -5.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | C$162.16B | 16.55 | 11.25% | 3.61% | -4.35% | 21.22% | |
72 Outperform | C$378.40B | 17.03 | 15.95% | 2.58% | 1.99% | 22.50% | |
71 Outperform | C$78.78B | 17.13 | 13.77% | 2.64% | 6.36% | 7.80% | |
70 Outperform | C$140.46B | 14.19 | 15.24% | 3.07% | -3.32% | 27.25% | |
68 Neutral | C$139.41B | 14.47 | 11.06% | 4.32% | -5.52% | 47.19% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | C$266.99B | 17.57 | 11.85% | 3.34% | -11.69% | -11.99% |